More frequent episodes of hypotension during dialysis and lower predialysis systolic blood pressure (BP) are associated with increased rates of thrombosis at the vascular access point, according to the findings of a recent analysis published in the Journal of the American Society of Nephrology.
In an update to its 2004 guidance on screening for bladder cancer, the United States Preventive Services Task Force (USPSTF) has changed its recommendation from a D (lack of evidence) to an I (insufficient evidence) statement, finding inadequate data to support disease screening for asymptomatic adults or for adults with mild lower urinary tract symptoms such as urinary frequency, hesitancy, urgency, dysuria, or nocturia.
The FDA has approved an update to the drug label for Reclast (zoledronic acid) so that health care professionals are better informed about the risk of renal failure associated with use of the drug.
One-to-one sessions to teach pelvic-floor exercises to men with urinary incontinence (UI) following radical prostatectomy or transurethral resection of the prostate proved no more effective than the standard of care.
The use of androgen-deprivation therapy (ADT) for two months before and two months during radiation therapy (RT) for early prostate cancer (PCa) is associated with significantly increased overall survival and decreased disease-specific mortality, researchers reported in the New England Journal of Medicine.
The Centers for Medicare & Medicaid Services (CMS) has issued a proposed rule that would update payment policies and rates under the End-Stage Renal Disease (ESRD) Prospective Payment System.
Physicians seldom following clinical guidelines for managing patients with high-grade, non-muscle-invasive bladder cancer, according to an online report in Cancer.
The overall number of deceased-donor kidney transplants rose 40% for minorities and 8% for non-Hispanic whites from the six years before to the six years after the U.S. kidney allocation system eliminated the allocation priority for matching of HLA-B antigens between candidates and potential deceased donors.
An analysis of 5,519 men undergoing biopsy in the control arm of the Prostate Cancer Prevention Trial uncovered no evidence to support the recommendation that men with high PSA velocity be biopsied in the absence of other indications, according to an online report in the Journal of the National Cancer Institute.
Please login or register first to view this content.
